Asia Pacific In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Instruments, And Services), By Technology (Immunoassays, Clinical Chemistry, Hematology, Molecular Diagnosis), By Application (Infectious Diseases, Oncology, Cardiology, Nephrology, Autoimmune Diseases, HIV), By End-Use And Segment Forecasts To 2024

Table of Content

Chapter 1. Methodology and Scope
                      1.1. Research methodology
                      1.2. Research scope & assumption
                      1.3. List of data sources
Chapter 2. Executive Summary
                      2.1. Asia Pacific In Vitro Diagnostics Market - Industry Summary and Key Buying Criteria, 2013 - 2024
Chapter 3. Asia Pacific In vitro diagnostics Market: Industry Outlook
                      3.1. Market segmentation
                      3.2. Market size and growth prospects, 2013 - 2024
                      3.3. Asia Pacific In vitro diagnostics Market: Market dynamics
                           3.3.1. Market driver analysis
                                   3.3.1.1. Increasing number of lifestyle diseases
                                   3.3.1.2. Rising awareness of customized medicines
                                   3.3.1.3. Increasing growth in geriatric population
                           3.3.2. Market restraint analysis
                                   3.3.2.1. Reimbursement issues
                                   3.3.2.2. Strict regulatory policies
                      3.4. In Vitro Diagnostics Market: Industry trend analysis
                      3.5. In Vitro Diagnostics Market:PESTEL Analysis
                      3.6. In Vitro Diagnostics Market Industry analysis - Porter's Five Forces Model
                      3.7. In Vitro Diagnostics market: Company Market Share Analysis (%), 2015
                      3.8. Key opportunities prioritized
Chapter 4. Asia Pacific In vitro diagnostics Market Product Outlook
                      4.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by Product, 2016 & 2024
                      4.2. Reagents and kits
                           4.2.1. Reagents and kits in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      4.3. Instruments
                           4.3.1. Instruments in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      4.4. Services
                           4.4.1. Services in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
Chapter 5. Asia Pacific In vitro diagnostics Market Technology Outlook
                      5.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by Technology, 2016 & 2024
                      5.2. Clinical Chemistry
                           5.2.1. Clinical chemistryin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      5.3. Immunoassays
                           5.3.1. Immunoassays in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      5.4. Hematology
                           5.4.1. Hematologyin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      5.5. Coagulation
                           5.5.1. Coagulation in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      5.6. Microbiology
                           5.6.1. Microbiology in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      5.7. Molecular Diagnostics
                           5.7.1. Molecular Diagnostics in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      5.8. Others
                           5.8.1. Otherin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
Chapter 6. Asia Pacific In vitro diagnostics Market Application Outlook
                      6.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by Application, 2016 & 2024
                      6.2. Diabetes
                           6.2.1. Diabetes in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      6.3. Infectious Diseases
                           6.3.1. Infectious Diseases in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      6.4. Oncology
                           6.4.1. Oncology in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      6.5. Nephrology
                           6.5.1. Nephrology in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      6.6. Cardiology
                           6.6.1. Cardiology in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      6.7. Autoimmune diseases
                           6.7.1. Autoimmune diseases in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      6.8. Drug Testing
                           6.8.1. Drug testingin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      6.9. Others
                           6.9.1. Otherin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
Chapter 7. Asia Pacific In Vitro Diagnostics Market End-User Outlook
                      7.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by End-User, 2016 & 2024
                      7.2. Hospitals
                           7.2.1. Drug testingin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      7.3. Laboratories
                           7.3.1. Laboratories in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      7.4. Homecare Diagnostics
                           7.4.1. Homecare Diagnosticsin vitro diagnostics market, by region, 2013 - 2024 (USD Million)
                      7.5. Others
                           7.5.1. Other in vitro diagnostics market, by region, 2013 - 2024 (USD Million)
Chapter 8. Asia Pacific In vitro diagnostics Market Regional Outlook
                      8.1. Asia Pacific In vitro diagnostics market Share (%) Analysis, by Country, 2016 & 2024
                           8.1.1. China
                                   8.1.1.1. China in vitro diagnostics market, by product, 2013 - 2024 (USD Million)
                                   8.1.1.2. China invitro diagnostics market, by technology, 2013 - 2024 (USD Million)
                                   8.1.1.3. China in vitro diagnostics market, by application, 2013 - 2024 (USD Million)
                                   8.1.1.4. China in vitro diagnostic market, by end-user, 2013 - 2024 (USD Million)
                           8.1.2. India
                                   8.1.2.1. India in vitro diagnostics market, by product, 2013 - 2024 (USD Million)
                                   8.1.2.2. India in vitro diagnostics market, by technology, 2013 - 2024 (USD Million)
                                   8.1.2.3. India in vitro diagnostics market, by application, 2013 - 2024 (USD Million)
                                   8.1.2.4. India in vitro diagnostic market, by end-user, 2013 - 2024 (USD Million)
                           8.1.3. Japan
                                   8.1.3.1. Japan in vitro diagnostics market, by product, 2013 - 2024 (USD Million)
                                   8.1.3.2. Japan in vitro diagnostics market, by technology, 2013 - 2024 (USD Million)
                                   8.1.3.3. Japan in vitro diagnostics market, by application, 2013 - 2024 (USD Million)
                                   8.1.3.4. Japan in vitro diagnostic market, by end-user, 2013 - 2024 (USD Million)
Chapter 9. Competitive Landscape
                      9.1. Becton, Dickinson and Company
                           9.1.1. Company Overview
                           9.1.2. Financial Performance
                           9.1.3. Product Benchmarking
                           9.1.4. Strategic Initiatives
                      9.2. bioMerieux, Inc.
                           9.2.1. Company Overview
                           9.2.2. Financial Performance
                           9.2.3. Product Benchmarking
                           9.2.4. Strategic Initiatives
                      9.3. Abbott Laboratories
                           9.3.1. Company Overview
                           9.3.2. Financial Performance
                           9.3.3. Product Benchmarking
                           9.3.4. Strategic Initiatives
                      9.4. Alere, Inc.
                           9.4.1. Company Overview
                           9.4.2. Financial Performance
                           9.4.3. Product Benchmarking
                           9.4.4. Strategic Initiatives
                      9.5. Hologic,Inc.
                           9.5.1. Company Overview
                           9.5.2. Financial Performance
                           9.5.3. Product Benchmarking
                           9.5.4. Strategic Initiatives
                      9.6. Cepheid, Inc.
                           9.6.1. Company Overview
                           9.6.2. Financial Performance
                           9.6.3. Product Benchmarking
                           9.6.4. Strategic Initiatives
                      9.7. Roche Diagnostics
                           9.7.1. Company Overview
                           9.7.2. Financial Performance
                           9.7.3. Product Benchmarking
                           9.7.4. Strategic Initiatives
                      9.8. Siemens Healthcare
                           9.8.1. Company Overview
                           9.8.2. Financial Performance
                           9.8.3. Product Benchmarking
                           9.8.4. Strategic Initiatives
                      9.9. Bio-Rad Laboratories, Inc.
                           9.9.1. Company Overview
                           9.9.2. Financial Performance
                           9.9.3. Product Benchmarking
                           9.9.4. Strategic Initiative

List of Tables

1. Asia Pacific IVD - Industry Snapshot & Key Buying Criteria, 2013 - 2024
2. Asia Pacific IVD market revenue, by product, 2013 - 2024 (USD Million)
3. Asia Pacific IVD market revenue, by technology, 2013 - 2024 (USD Million)
4. Asia Pacific IVD market revenue, by application, 2013 - 2024 (USD Million)
5. Asia Pacific IVD market revenue, by end-user, 2013 - 2024 (USD Million)
6. Asia Pacific IVD market, by region, 2013 - 2024 (USD Million)
7. Asia Pacific IVD- Key Market Driver Analysis
8. Asia Pacific IVD- Key Market Restraint Analysis
9. Asia Pacific IVD market revenue, 2013 - 2024 (USD Million)
10. China IVD market revenue, by product, 2013 - 2024 (USD Million)
11. China IVD market revenue, by technology, 2013 - 2024 (USD Million)
12. China IVD market revenue, by application, 2013 - 2024 (USD Million)
13. China IVD market revenue, by end-user, 2013 - 2024 (USD Million)
14. India IVD market revenue, by product, 2013 - 2024 (USD Million)
15. India IVD market revenue, by technology, 2013 - 2024 (USD Million)
16. India IVD market revenue, by application, 2013 - 2024 (USD Million)
17. India IVD market revenue, by end-user, 2013 - 2024 (USD Million)
18. Japan IVD market revenue, by product, 2013 - 2024 (USD Million)
19. Japan IVD market revenue, by technology, 2013 - 2024 (USD Million)
20. Japan IVD market revenue, by application, 2013 - 2024 (USD Million)
21. Japan IVD market revenue, by end-user, 2013 - 2024 (USD Million)

List of Figures

1. Asia Pacific IVD: Market segmentation
2. Asia Pacific IVD, 2013 - 2024 (USD Million)
3. Asia Pacific IVD market: Industry trend analysis
4. Asia Pacific IVD market: PESTEL analysis
5. Asia Pacific IVD market: Porter’s analysis
6. Asia Pacific IVD company market share, 2015
7. Key Opportunities Prioritized
8. Asia Pacific IVD market revenue share, by product, 2016 & 2024
9. Reagents Market Revenue, 2013 To 2024 (USD Million)
10. Instruments Market Revenue, 2013 To 2024 (USD Million)
11. Services market Revenue, 2013 to 2024 (USD Million)
12. Asia Pacific In vitro diagnostic (IVD) market revenue share, by technology, 2016 & 2024
13. Immunoassays market revenue, 2013 to 2024 (USD Million)
14. Clinical chemistry market revenue, 2013 to 2024 (USD Million)
15. Hematology market revenue, 2013 to 2024 (USD Million)
16. Molecular diagnosis market revenue, 2013 to 2024 (USD Million)
17. Microbiology market revenue, 2013 to 2024 (USD Million)
18. Coagulation market revenue, 2013 to 2024 (USD Million)
19. Asia Pacific IVD market revenue share, by application, 2016 & 2024
20. Infectious diseases market revenue, 2013 to 2024 (USD Million)
21. Diabetes market revenue, 2013 to 2024 (USD Million)
22. Oncology market revenue, 2013 to 2024 (USD Million)
23. Cardiology market revenue, 2013 to 2024 (USD Million)
24. Nephrology market revenue, 2013 to 2024 (USD Million)
25. Autoimmune diseases market revenue, 2013 to 2024 (USD Million)
26. Drug testing market revenue, 2013 to 2024 (USD Million)
27. Asia Pacific IVD market revenue share, by end-user, 2016 & 2024
28. Hospitals market revenue, 2013 to 2024 (USD Million)
29. Laboratories market revenue, 2013 to 2024 (USD Million)
30. Homecare diagnostics market revenue, 2013 to 2024 (USD Million)
31. Others market revenue, 2013 to 2024 (USD Million)
32. Asia Pacific IVD market share, by region, 2016 & 2024
33. China market revenue, 2013 to 2024 (USD Million)
34. India market revenue, 2013 to 2024 (USD Million)
35. Japan market revenue, 2013 to 2024 (USD Million)